![](https://endpts.com/wp-content/uploads/2017/07/protocols-two.jpg)
Japanese biotech pitching iPSC-derived med for the heart gains $26M; Andreessen Horowitz leads $4.1M seed funding for AI upstart
→ A longtime researcher in cardiac regenerative medicine has closed a $26 million Series B to advance his development of iPSC-derived cardiomyocytes as a treatment …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.